Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE:002294)
China flag China · Delayed Price · Currency is CNY
40.74
+1.34 (3.40%)
Apr 29, 2025, 3:04 PM CST

SHE:002294 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2015 - 2019
Operating Revenue
3,9103,2803,4013,0202,731
Upgrade
Other Revenue
102.7385.6781.2738.737.07
Upgrade
Revenue
4,0123,3653,4823,0582,739
Upgrade
Revenue Growth (YoY)
19.22%-3.35%13.85%11.68%-38.74%
Upgrade
Cost of Revenue
1,1381,0651,001811.29847.87
Upgrade
Gross Profit
2,8742,3002,4812,2471,891
Upgrade
Selling, General & Admin
1,7451,3021,3321,3401,187
Upgrade
Research & Development
421.24409.19533.75357.37371.2
Upgrade
Other Operating Expenses
18.7620.246.9344.9834.67
Upgrade
Operating Expenses
2,1901,7341,9161,7431,584
Upgrade
Operating Income
683.93565.82565.58504.3306.3
Upgrade
Interest Expense
-16.17-17.37-12.54-10.53-17.57
Upgrade
Interest & Investment Income
80.0980.94151.26181.935.5
Upgrade
Currency Exchange Gain (Loss)
1.693.015.55-5.78-5.35
Upgrade
Other Non Operating Income (Expenses)
-1.37-0.43-5.84-7.54-21.46
Upgrade
EBT Excluding Unusual Items
748.17631.96704662.35297.43
Upgrade
Impairment of Goodwill
--49.61-26.61--282.72
Upgrade
Gain (Loss) on Sale of Investments
14.518.093.81--26.78
Upgrade
Gain (Loss) on Sale of Assets
-0.15-0.48-0.18-1.30.21
Upgrade
Asset Writedown
-159.64-2.89-24.06-131.6-1.59
Upgrade
Other Unusual Items
29.6254.6856.7670.3970.21
Upgrade
Pretax Income
632.52641.76713.73599.8456.74
Upgrade
Income Tax Expense
27.3660.9379.3671.526.61
Upgrade
Earnings From Continuing Operations
605.16580.83634.37528.3250.13
Upgrade
Minority Interest in Earnings
-3.59-0.762.735.4110.73
Upgrade
Net Income
601.57580.07637.09533.7360.86
Upgrade
Net Income to Common
601.57580.07637.09533.7360.86
Upgrade
Net Income Growth
3.71%-8.95%19.37%776.90%-91.49%
Upgrade
Shares Outstanding (Basic)
1,1141,1161,0981,0671,014
Upgrade
Shares Outstanding (Diluted)
1,1141,1161,0981,0671,014
Upgrade
Shares Change (YoY)
-0.13%1.55%2.90%5.23%-3.55%
Upgrade
EPS (Basic)
0.540.520.580.500.06
Upgrade
EPS (Diluted)
0.540.520.580.500.06
Upgrade
EPS Growth
3.85%-10.35%16.00%733.33%-91.18%
Upgrade
Free Cash Flow
561.45168.44371.84702.48731.86
Upgrade
Free Cash Flow Per Share
0.500.150.340.660.72
Upgrade
Dividend Per Share
0.5000.5000.5000.400-
Upgrade
Dividend Growth
--25.00%--
Upgrade
Gross Margin
71.64%68.34%71.26%73.47%69.04%
Upgrade
Operating Margin
17.05%16.81%16.24%16.49%11.19%
Upgrade
Profit Margin
14.99%17.24%18.30%17.45%2.22%
Upgrade
Free Cash Flow Margin
13.99%5.00%10.68%22.97%26.72%
Upgrade
EBITDA
1,045893.22873.67798.4552.33
Upgrade
EBITDA Margin
26.03%26.54%25.09%26.11%20.17%
Upgrade
D&A For EBITDA
360.6327.4308.09294.1246.03
Upgrade
EBIT
683.93565.82565.58504.3306.3
Upgrade
EBIT Margin
17.05%16.81%16.24%16.49%11.19%
Upgrade
Effective Tax Rate
4.33%9.50%11.12%11.92%11.64%
Upgrade
Revenue as Reported
4,0123,3653,4823,0582,739
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.